A comparison of clinical staging using the Lugano versus Ann Arbor classifications in Japanese patients with Hodgkin lymphoma.

Shinichi MakitaDai MaruyamaAkiko Miyagi MaeshimaHirokazu TaniguchiSayako YudaKosuke ToyodaNobuhiko YamauchiSuguru FukuharaWataru MunakataYukio KobayashiHiroaki KuriharaKoji IzutsuKensei Tobinai

Published in: Asia-Pacific journal of clinical oncology (2019)

Our data revealed a high concordance rate between the Lugano and Ann Arbor staging system in Japanese patients with HL. Because of its low diagnostic value, routine bone marrow examination might be unnecessary for staging when FDG-PET/CT is used as a substitute.

Keyphrases

hodgkin lymphoma
lymph node
bone marrow
pet ct
mesenchymal stem cells
electronic health record
big data